Sign up Australia
Proactive Investors - Run By Investors For Investors

WeedMD's second quarter underlines management's ability, reckons broker Haywood, which repeats 'buy'

The firm reported revenue for the three months to end June of C$2.01mln, up 83% on the previous quarter.
WeedMD's second quarter underlines management's ability, reckons broker Haywood, which repeats 'buy'
The company expects 500,000 sq ft of production space to be online by the end of this year

WeedMD Inc's (CVE:WMD) second quarter solid revenue growth showed management's ability to execute on strategy, reckons broker Haywood Securities, which has repeated a 'buy' stance and target of C$3.25.

Yesterday, the firm posted revenue for the three months to end June of C$2.01mln, which was 83% up on the previous quarter to end March.

READ: WeedMD confident about building market share as revenues soar in latest half year

Revenue of C$3.2mln for the first half represented a whopping 1,271% increase compared to the first half of fiscal 2017.

"We believe that WeedMD is well-positioned for both the medical market and adult-use market in Canada," said Haywood analyst Neal Gilmer in a note.

"With close to $40M in cash and a fully funded expansion plan, the company is on track to significantly expand production by the end of this year.

"With various provincial supply agreements in place, as well as the recently announced agreement with Shopper's Drug Mart, it is our view that the company is positioned for solid growth in 2019," he added.

That said, the broker noted the company expects 'marginal' revenue growth in the third quarter, due to a suspension of wholesale product sales and seedling sales as it ramps up production at its Strathroy greenhouse in Ontario.

READ: WeedMD Inc announces cannabis supply deal with Nova Scotia liquor corporation; shares pop

In late June initial crops were successfully moved into three grow rooms at Strathroy, or 25,000 sq ft.

Harvest of these rooms is on schedule for September this year, noted Gilmer, while the company expects a further 60,000 sq ft to be licensed and online during the fall of 2018 and the remaining 410,000 sq ft to be retrofitted and online by the end of the year.

"In addition, the company has signed supply agreements with Alberta, British Columbia, and Nova Scotia," said the analyst.

The broker noted that as with  other pot stocks it covers, it has lowered the 2018 estimates due to the timing of the adult-use legalization.

Haywood values WeedMD based on a multiple of ten times EV/EBITDA (enterprise value/ EBITDA) on its 2020 estimates, discounted by 15% to bring to one year forward basis.

WeedMD shares in Toronto are up Wednesday 6.04% to C$1.93.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
1539364967_Cannabis-plant.jpg
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use